Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort
Arjan C. Lankester(Leiden University Medical Center), Kim Vettenranta(Universität Hamburg), Rita Beier(Medizinische Hochschule Hannover), Krzysztof Kałwak(Poznan University of Medical Sciences), Mikael Sundin(Karolinska University Hospital), Bénédicte Neven(Université Paris-Panthéon-Assas), Marina Cavazzana(Université Rennes 2), Aydan İkincioğulları(Ankara University), Karoline Ehlert(Universitätsmedizin Greifswald), Herbert Pichler(St Anna Children's Hospital), Manfred Hoenig, Alina Ferster(Université Libre de Bruxelles), Natacha Entz‐Werlé(Hôpital d'Hautepierre), Robbert G. M. Bredius(Leiden University Medical Center), Despina Moshous(Hôpital Necker-Enfants Malades), Elena Soncini(University of Brescia), Peter Bader(Goethe University Frankfurt), Michael H. Albert(LMU Klinikum), Marta González‐Vicent(Hospital Infantil Universitario Niño Jesús), Arnalda Lanfranchi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Figen Doğu(Ankara University), Jolanta Goździk(Jagiellonian University), Amos Toren, Nuno Miranda(IPO Porto), Virginie Courteille, Caroline A. Lindemans(University Medical Center Utrecht), Roland Meisel(Düsseldorf University Hospital), Alphan Küpesiz(Akdeniz University), Nizar Mahlaoui(Hôpital Necker-Enfants Malades), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Erik G. J. von Asmuth(Leiden University Medical Center), Mikael Alligon(Hôpital Necker-Enfants Malades), José M. Moraleda(Centro Regional de Hemodonación), Anders Fasth(University of Gothenburg), Mary Slatter(First Pavlov State Medical University of St. Petersburg), Renata Formánková(Charles University), Victoria Bordon(Ghent University Hospital), Dmitry Balashov(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Savaş Kansoy(Ege University), Petr Sedláček(University Hospital in Motol), Isabelle Serra(Hospital de Sant Pau), Yves Bertrand(Université Claude Bernard Lyon 1), Tayfun Güngör, Stéphane Blanche(Délégation Paris 5), Gérard Michel(Hôpital de la Timone), Andrew J. Cant(Clinical Research Institute), Wilhelm Friedrich, Francesca Ferrua(Vita-Salute San Raffaele University), Kanchan Rao(Great Ormond Street Hospital), Carsten Speckmann(University of Freiburg)
Cited by 110
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k